Spatial statistics infer structured immune signatures in primary prostate cancer
The spatial arrangement of immune cells in the tumor microenvironment (TME) varies widely, from dispersed to clustered and tumor excluded to infiltrating. Multiplexed spatial profiling is an effective means of characterizing tumor-infiltrating lymphocytes (TILs) and immune complexes such as tertiary lymphoid structures (TLS) in the TME. However, few approaches have been described for objectively parametrizing patterns of immune organization and assessing their association with biological or clinical variables. This makes it difficult to evaluate whether a set of tumors is relatively immunologically cold or hot. Here we describe an intuitive set of statistical tools (available in the R package, tlsR) for characterizing lymphocyte patterns in the TME of solid cancers. We applied tlsR to primary prostate cancer (PCa), which is often described as immunologically 'cold'. Using a cohort of 29 radical prostatectomy specimens stratified into low Gleason-grade (LGG; n=15) and high Gleason-grades (HGG; n =14) we showed that HGG PCa is significantly more infiltrated than LGG PCa with lymphocytes organized into B cell or T cell enriched immune clusters (BICs and TICs). A subset of these ICs had the B and T cell zonation and follicular dendritic cells characteristic of a bona fide TLS. HGGs were also enriched with ICs containing precursor exhausted T cells (Tpex) and proliferating B cells and their tumor compartments harbor granzyme-B+ cytotoxic T cells in contact with cancer cells. Thus, far from being cold, a subset of HGG PCa has features associated with active immune surveillance, a finding with implications for emerging PCa immunotherapies.
Authors
- Fabio Socciarelli
- Andréanne Gagné (ORCID: https://orcid.org/0000-0002-3833-4159)
- Ali Amiryousefi (ORCID: https://orcid.org/0000-0002-6317-3860)
- Giuseppe Nicolò Fanelli (ORCID: https://orcid.org/0000-0001-7069-7980)
- Jeremiah A. Wala (ORCID: https://orcid.org/0000-0001-6591-1620)
- Zoltan Maliga (ORCID: https://orcid.org/0000-0003-4209-7253)
- Madeleine S. Durkee (ORCID: https://orcid.org/0000-0003-0543-074X)
- Eliezer M. Van Allen (ORCID: https://orcid.org/0000-0002-0201-4444)
- Aishwarya Atmakuri (ORCID: https://orcid.org/0000-0002-1648-3890)
- Eamon Toye (ORCID: https://orcid.org/0009-0003-6546-9387)
- Jia‐Ren Lin (ORCID: https://orcid.org/0000-0003-4702-7705)
- Peter K. Sorger (ORCID: https://orcid.org/0000-0002-3364-1838)
- Akash Patnaik (ORCID: https://orcid.org/0000-0001-5306-0208)
- Shannon Coy (ORCID: https://orcid.org/0000-0003-0033-9031)
- Kiranj Chaudagar (ORCID: https://orcid.org/0000-0002-8113-8516)
- Brian Labadie (ORCID: https://orcid.org/0000-0002-3648-4663)
- Brigette Kobs (ORCID: https://orcid.org/0000-0003-3417-7472)
Institutions
- University of Pisa (IT)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Emory University (US)
- Cornell University (US)
- Harvard University Press (US)
- University of Massachusetts Boston (US)
- University of Illinois Chicago (US)
- University of Chicago (US)
- Dana-Farber Cancer Institute (US)
- Dana-Farber/Harvard Cancer Center (US)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Weill Cornell Medical College in Qatar (QA)
- University of Pennsylvania (US)
Publication Details
- Journal
- Cancer Immunology Research
- Published
- 2026-09-11
- DOI
- https://doi.org/10.1158/2326-6066.cir-26-0106
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00